Cordis is a worldwide leader in the development and manufacturing of interventional vascular technology with a more than 50year history of pioneering products to treat millions of patients. The combining clinical safety and easeofuse, the cordis exoseal vascular closure device means a more confident close and improved patient. The exoseal vascular closure device is indicated for femoral artery puncture site closure, reducing times to hemostasis and ambulation in patients who have undergone diagnostic or interventional catheterization procedures using a standard 5f, 6f, or 7f vascular sheath introducer with up to a 12cm working length. Suitability of exoseal vascular closure device for antegrade.
The exoseal vascular closure device is supplied preassembled. Cordis exoseal vascular closure device instructions for use i. The mynxgrip device achieves secure extravascular closure by utilizing the grip sealant, which actively adheres to the artery or vein. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Cordis, ex600, cordis exoseal vascular closure device, 6f. Evaluation of the 6f exoseal vascular closure device in. Precise, linear digital pressure control within a closedloop system with ultra high resolution and repeatability. Cordis launches mynx control vascular closure device in. A retrospective study comparing the effectiveness and safety of exoseal vascular closure device to manual compression in patients undergoing percutaneous transbrachial procedures. Community research and development information service. Cordis, a johnson and johnson company, exoseal tm 6f vascular closure device, cat. Videos of the cordis johnson and johnson exoseal vascular.
Clinical data from the eclipse trial indicates safety in terms of vascular injury, access siterelated bleeding, infection or nerve injury, new ipsilateral lower extremity ischemia or sae. A retrospective study comparing the effectiveness and. An exoseal vascular closure device 6f was used for closure in all cases. Cordis exoseal vascular closure device combining clinical safety and easeofuse, the cordis exoseal vascular closure device means a more confident close and improved patient outcomes. Bridgewater, nj may 20, 2011 cordis corporation, a worldwide leader in the development and manufacture of interventional vascular technology, today announced the approval of the exoseal vascular closure device in the us. Exoseal est actuellement disponible en 6 french et le sera prochainement en 5 et 7 f. Perclose proglide smc system delivers a secure, nonmasking percutaneous suture to the access site that promotes primary healing 1 and has no reaccess restrictions. Product, cordis, a johnson and johnson company, exosealtm 6f vascular closure device, cat. Cordis launches exoseal vascular closure device vascular. Cardiovascular catalog page 20 cordis diagnostic catheter portfolio right coronary judkins technique 100 cm infiniti catheter infiniti catheter infiniti catheter super torque plus catheter super torque plus catheter 7f highflow catheter jr 3. The act was measured before the sheath was removed.
Randomized comparison of exoseal and angioseal vascular. Class 2 device recall cordis exoseal vascular closure device. Jun 19, 2014 exoseal cordis corporation, bridgewater, new jersey, usa is a vascular closure device consisting of a plug applier and a bioabsorbent polyglycolic acid plug available in sizes 5 f, 6 f, and 7 f. Cordis exoseal vascular closure device easytouse functionality trusted bioabsorbable technology precise extravascular closure excellent clinical results for clinically safe, confident close resulting in improved patient outcomes, use the cordis exoseal vascular closure device clinical data from the eclipse trial indicates. This database also contains valuelink directions for use dfu or instructions for use ifu that are provided by the manufacturer with fullcase or box quantities of the products. The sealant dissolves within 30 days, leaving nothing permanently behind but a healed artery. Quickly and securely seal femoral artery punctures with the angioseal vip vascular closure device. This video from rodolfo lanocita md, of the istituto nazionale dei tumori, milan, demonstrates deployment of the exoseal vascular closure device from cordis. The tool, used to close the femoral artery puncture site during diagnostic angiographies and interventional procedures. We combine awardwinning creative treatments with highend technology to make polished and professional video production affordable. May 01, 2010 new trial results on exoseal tm vascular closure device support its clinical safety and efficacy. Exoseal femoral access vascular closure device youtube. Exoseal cordis, warren, nj, usa is a new, extravascular polyglycol acid pga plug which occludes the puncture channel.
To assess the efficacy and safety of the exoseal vascular closure device for antegrade puncture of the femoral artery. Active vascular closure devices sutures perclose abbott vascular perclose proglide prostar the 6 fr proglide is designed for 58 fr sheaths. The grip sealant, comprised of polyethylene glycol peg, grips the artery, providing a secure close. The mynxgrip device is also indicated to close femoral venous access sites utilizing a 5f, 6f, or 7f procedural sheath. Combining clinical safety and easeofuse, the cordis exoseal vascular closure device means a more confident close and improved patient outcomes. The exoseal vascular closure device is designed for a safe, simple, and secure close. The sealant dissolves within 30 days, leaving nothing permanently behind but.
Additional compression bandaging was applied to the puncture site for at least 6 hours. Listen to music from cordisex like stromae formidable. Suitability of exoseal vascular closure device for. Plug applier consists of a handle assembly and a delivery shaft. This study aimed to assess the safety and efficacy of exoseal vascular closure device evcd insertion by. This video from cordis shows the exoseal vascular closure device in use. Device name the device brand name is the cordis exosealtm vascular closure device vcd. Exoseal cordis, warren, nj, usa is a new, extravascular polyglycol acid pga. Used for femoral artery puncture site closure, reducing times to hemostasis and ambulation in patients who have undergone diagnostic or interventional procedures. Evaluation of the 6f exoseal vascular closure device in antegrade femoral artery punctures article in journal of endovascular therapy 196.
Cordis received ce marking approval for exoseal in may 2010. Mar 15, 2014 active intestine submucosa fish clip starclip evs suture perclose proglide perclose prostar cardiva catalystiii plug collagen angioseal vasoseal polyglycolic acid mynx exoseal duett 61. The evcd made by cordis company consists of a plug applier and an absorbable plug. Exoseal cordis corporation, bridgewater, new jersey, usa is a vascular closure device consisting of a plug applier and a bioabsorbent polyglycolic acid plug available in sizes 5 f, 6 f, and 7 f.
Successful bailout procedure for acute popliteal artery. The clippard cordis is a revolutionary microcontroller primed for escape velocity from a proportional control market that has grown stagnant. Cordis has announced the launch of the exoseal vascular closure device. May 27, 2010 paris, may 27, 2010 prnewswire new trial results on exoseal tm vascular closure device support its clinical safety and efficacy. With a reputation for clinical acumen, training and services.
Cordis has received fda approval for its exoseal vascular closure device. In a prospective study from february 2011 to january 2012, a total of 93 consecutive patients received a total of 100 interventional procedures via an antegrade puncture of the femoral artery. The eufunded video project is developing the next instrument generation for earth observation. A press release reports that the mynx control vascular control device integrates active extra vascular sealing and resorbability properties with a nextgeneration delivery system to maximise predictability, safety, and ease of use in sealing 57fr femoral arterial access. Wong sc, bachinsky w, cambier p, et al, for the eclipse trial investigators. Femoral artery closure plugpatch, synthetic polymer a sterile, implantable, bioabsorbable device designed for haemostasisclosure of a puncture site, through pressurecompression, on a patient having undergone femoral artery catheterization. Find the latest tracks, albums, and images from cordisex. Exoseal for puncture site closure after antegrade procedures. Exoseal is inserted into the branch canal directly outside the arterial vessel wall and underneath the fascia of the neurovascular bundle. Cordis receives fda approval for exoseal vascular closure device. Cordis, ex500, cordis exoseal vascular closure device, 5f. Nov 19, 2006 recently found 2 patients out of icu with introducer cordis left in place when patient was transferred to regular floor also at a recent local ins meeting the subject was brought upprobably new nurses unaware that this is a poor practicewhat is the standard as applies to these devices outside of the icuare they covered under the standard that states catheter should be removed when it.
As of october 2015, cordis is a part of cardinal health, bringing together two important players in the healthcare industry and creating an unmatched combined offering in the cardiovascular space that will ensure greater access to quality products and services worldwide. A retrospective study comparing the effectiveness and safety of. Description the exoseal vascular closure device vcd consists of a plug applier and an absorbable plug. Cordis corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced the launch of the exoseal tm vascular closure device. Easytouse functionality trusted bioabsorbable technology precise. This system has the broadest arterial and venous indication. Vascular closure devices vcds are medical devices used to achieve hemostasis of the small hole in the artery after a cardiovascular procedure of endovascular surgery requiring a catheterization. Please note that you must be trained in the use of this device by a cordis johnson and johnson representative.
The vtwist integrated platform vip is a unique technology providing a larger collagen footprint for better arteriotomy coverage and enhanced conformability around the artery. A the operator inserted the evcd to the marker band through the vascular sheath and the bleedback indicator, where the blood could be seen. This video from cordis provides a detailed description of the exoseal vascular closure device and deployment procedure. An extrawide field of view and video observation is the next step.
Excellent clinical results clinical data from the eclipse trial indicates safety in terms of. Cordis receives fda approval for exoseal vascular closure device bridgewater, nj may 20, 2011 cordis corporation, a worldwide leader in the development and manufacture of interventional vascular technology, today announced the approval of the exoseal vascular closure device in the us. Aug 21, 2012 despite higher complications rates in earlier studies, current data suggest similar complication rates or better outcomes after the use of vcd as compared to manual compression. May 26, 2011 this video from rodolfo lanocita md, of the istituto nazionale dei tumori, milan, demonstrates deployment of the exoseal vascular closure device from cordis. Cordis corporation today announced the approval of the exoseal vascular closure device in the us. To view this video, please sign in or register free. Video recording using sony 3 chip camera hdv 1080i video editing using finalcut pro and titles and graphics produced in motion.
Video imaging demonstrator for earth observation cordis. Our software enhances interoperability by combining the raw power of sap with the simplicity. Videos cordis exoseal step by step which medical device. Inhospital and 30 days safety and efficacy endpoints and 6 months safety endpoints will be reported. The exoseal tm vascular closure device makes use of key technological developments to support the clinical safety and efficacy of the closure procedure. This site is intended for cardinal healths customers to provide immediate access to the most current material safety data sheets msdssds. A retrospective study comparing the effectiveness and safety. After the sheath was removed using the 7f exoseal, manual compression was applied for 5 minutes. Exoseal vascular closure device international medical devices. New trial results on exoseal tm vascular closure device support its clinical safety and efficacy.
Cardinal health and cordis quality products and services from a trusted source. Your browser does not currently recognize any of the video formats available. Over 250,000 doctors use vumedi to improve patient care and grow their practice. Exoseal tm incorporates a number of new advances in. Vascular closure system with anchor exoseal cordis videos. Cordis receives fda approval for exoseal vascular closure. The plug applier consists of a handle assembly and a delivery shaft see figure 1. Exoseal incorporates a number of new advances in technology and simplicity of design to provide precise and secure extravascular arterial closure. The exoseal vcd is more advantageous than other vcds because it leaves nothing behind inside the vessel, which reduces the risks of anchorrelated luminal narrowing, occlusion, and distal embolisms. Class 2 device recall cordis exoseal vascular closure device fda. Perclose proglide suturemediated closure system abbott.
Satellite images can show environmental changes occurring gradually, like the spread of air pollution over a certain continent. The exoseal vascular closure device is indicated for femoral artery puncture site closure, reducing times to hemostasis and ambulation in patients who have undergone diagnostic or interventional catheterization procedures using a standard 5f, 6f, or 7f. A randomized comparison of a novel bioabsorbable vascular closure device versus manual compression in the achievement of hemostasis after. Among them, the exoseal cordis, nj, usa vcd can deliver a bioabsorbable polyglycolic acid plug to fill the subcutaneous puncture route at the groin. Cordis solutions is committed to helping customers release more value from their sap erp investments.
The investigational exoseal device cordis, miami fl is a novel 3rd generation 6 fr. Step by step procedure to obtain femoral hemostasis after an angiographic procedure. Several authors have reported the safety and efficacy of exoseal vcds for the closure of puncture sites made by introducer sheaths of a diameter equivalent to that of the vcd. Internal communications video production cordis video. You can also disable the family filter in the user. Paris, may 27, 2010 prnewswire cordis corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced the launch of the exoseal tm vascular closure device. The absorbable plug is fully enclosed in the distal portion of the delivery shaft. Paris, may 27, 2010 prnewswire new trial results on exoseal tm vascular closure device support its clinical safety and efficacy.
Commotio cordis is discussed as a preventable sportsrelated injury in the adolescent age group. The cordis exoseal vascular closure device enables femoral artery puncture site closure. In both diagnostic and interventional cases, the angioseal vip. In this study, 6f vcd was chosen based on the diameter of the brachial artery. A 7f exoseal vcd was used for hemostasis in all cases. It is the european commissions primary public repository and portal to disseminate information on all eufunded research projects and their results in the broadest sense. Videos cordis exoseal realtime case which medical device. A bioabsorbable pgaplug polyglycolic acid, is designed to close the femoral artery puncture site with minimal or no inflammation. Cordis is the community research and development information service. Cordis video internal communications video production. Cordis exoseal vascular closure device instructions for. The exoseal vascular closure device is indicated for femoral artery puncture site closure, reducing times to hemostasis and ambulation in patients who have undergone diagnostic or interventional catheterization procedures using a standard 5f, 6f, or 7f vascular sheath introducer with up to a 12cm working length the exoseal vascular closure device is designed for a safe, simple, and.